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Abstract 
Hydroxyapatite (HA) is widely used as a coating on orthopedic medical implants to improve anchoring to bone 
tissue and facilitate bone repair. The use of plasma-sprayed HA coatings on metal implants has raised as much 
controversy as interest over the last decade. Although faster and stronger fixation and enhanced bone growth have been 
reported, the long-term performance of HA-coated implants has been questionned This ambivalent behaviour is related 
to the thermal decomposition of HA during the plasma spraying of HA powder, which has several observable 
consequences for the physical-chemical and biological properties of the coatings. This review presents the current 
knowledge on the characteristics of plasma-sprayed HA coatings and their biological consequences. Various schemes 
of chemical reactions and physical-chemical processes that can occur during HA-particle plasma spraying, HA-coating 
formation, or after implantation of HA coatings are presented. Standard and emerging methods developed for the 
characterization of HA coatings are reviewed, with a focus on Raman spectroscopy, which allows high-quality imaging. 
Finally, several promising trends that have been explored in recent years to improve the mechanical resistance of 
coatings and their adhesion on the substrate, to improve the coating microstructure and crystallinity, or to confer a 
therapeutic activity (e.g., antibacterial activity) on plasma-sprayed HA coatings are reviewed. 
Keywords: Hydroxyapatite, Plasma-sprayed coatings, Thermal decomposition, Characterization 
1. Introduction
Plasma spraying hydroxyapatite (HA) remains the most 
commonly used process for giving biological properties to 
orthopedic and dental metal implants, especially 
osteoconductive capabilities and efficient primary biointegration 
into bone tissue. Plasma spraying techniques have the ability to 
construct thick, adherent, and biologically active HA coatings 
[1-5]. However, it is well established that HA decomposes 
during plasma spraying, leading to the formation of various 
phases [1-13]. This decomposition has several drawbacks for the 
behavior of coatings after implantation, such as degradation, 
release of particulates, and delamination due to a loss of 
cohesion and poor metal-coating bonding. Plasma-sprayed 
coatings are usually composed of large crystalline HA particles 
embedded into a relatively soluble amorphous phase. 
Several physical-chemical properties of plasma-sprayed 
HA coatings have been standardized with regard to their 
chemical composition (Ca/P ratio), phase composition, and 
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crystallinity [14]. Most of these parameters are based on X-ray 
diffraction (XRD) analyzes. However, several additional 
parameters that are more difficult to determine, such as 
crystalline phase distribution within the coating, the amount of 
amorphous phase, and the oxyapatite (OA) fraction, are not 
considered in the standards although they could be related to 
the coating behavior in vitro and in vivo. 
This review presents the current knowledge on the 
characteristics of plasma-sprayed HA coatings and their 
biological consequences. The reactions involved in the thermal 
decomposition of HA are summarized, and the consequences of 
these reactions for the coating characteristics are discussed. The 
biological consequences and recent developments are also 
reviewed. 
2. Thermal decomposition of apatites
The thermal decomposition of HA occurs in two steps: an 
irreversible decomposition reaction in the range 200-800 °C 
and a reversible decomposition above 1000 °C. 
2.1 Irreversible decomposition 
Generally, HAs used in plasma spraying are prepared in 
aqueous media either by using a double decomposition reaction 
between soluble calcium and phosphate salts, for example 
ammonium phosphate and calcium nitrate, or by neutralization 
of a calcium hydroxide suspension with a phosphoric acid 
solution [13]. After their synthesis, HAs may contain several 
impurities such as counter ions as well as HPO4
2- and carbonate
ions related to the weak dissociation constant of HPO4
2- and
contamination of the solutions with atmospheric CO2. 
According to several studies, the chemical composition of such 
apatites can be represented as: 
Ca10-x-y+z (PO4)6-x-y (HPO4)x(CO3)y (OH)2-x-y+2z
with 0 ≤ x+y ≤ 2 and 0 ≤ 2z ≤ x+y 
The heating of unstable species like HPO4
2- and CO3
2- can
lead to several irreversible reactions: 
2 HPO4
2- ® P2O7
4- + H2O 200-600 °C range 
CO3
2- + 2 HPO4
2-® PO4
3- + H2O + CO2  200-600 °C range 
CO3
2- + P2O7
4- ® PO4
3- + CO2 300-700 °C range 
P2O7
4- + 2 OH- ® PO4
3- + H2O 600-800 °C range 
At temperatures between 850 and 1000 °C, the mineral 
phases coexisting with HA depend only on the Ca/P ratio of the 
apatite (Fig. 1). 
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Figure 1. Thermal decomposition of apatite. Reversible and irreversible 
reactions as functions of temperature. 
2.2 Reversible high-temperature decomposition 
Several phase diagrams have been provided for the CaO- 
P2O5 system, with water vapor not considered in most cases 
[15,16]. However, it is well established that the decomposition 
of stoichiometric HA begins with dehydroxylation and the 
formation of OA related to the loss of water [17]: 
Ca10 (PO4)6 (OH)2 « Ca10 (PO4)6 O + H2O 
This reaction is reversible and depends on the water vapor 
pressure. It seems to begin at about 850 °C in vacuum. Pure 
OA is very difficult to obtain and generally the prepared 
samples contain residual OH- ions. Between 1050 °C and 
1550 °C, oxy-hydroxyapatite (OHA) begins to decompose into 
tricalcium phosphate (TCP) and tetracalcium phosphate 
(TTCP): 
Ca10 (PO4)6 O « Ca3(PO4)2 + Ca4(PO4)2O 
Various values of this decomposition temperature, which 
increases with the water partial pressure, have been reported 
[16,18]. At higher temperature (1570 °C), a liquid phase, which 
is believed to correspond to a eutectic mixture is obtained. 
However some reports mention the existence of CaO resulting 
from the decomposition of HA within the liquid phase [5]. 
3. Foreign phases in plasma-sprayed coatings
The plasma spraying processes used by several medical 
manufacturers consist of the acceleration and heating at very 
high temperatures of HA crystalline particles introduced in a 
plasma flame produced by an electrical discharge between 
electrodes. The partly (or totally) melted HA particles impact 
the substrate, where they rapidly cool, resulting in a coating 
microstructure with a lamellar structure. These thermal events 
lead to a partial decomposition of the apatite structure and 
several foreign phases are generally observed in the coatings 
after cooling (Table 1). The possible formations of these phases 
are shown in Table 1. Multiple thermal events have to be 
considered: the rapid heating of in-flight particles, the 
quenching of the HA particles upon impact with the target, and 
the partial re-heating and cooling in multiple torch passes. The 
first layer is different from subsequent ones since it is deposited 
on a metal (most generally titanium or one of its alloys), which 
has good thermal conductivity. The other layers impact 
thermally insulating splats that have already been deposited, 
and thus their quenching is much less efficient and is associated 
with local re-heating and slow cooling. 
Table 1. Phases found in plasma-sprayed HA coating and solubility 
products of various calcium phosphates. 
Phase Formula Formation 
-log Ksp 
at 25°C 
Calcium oxide CaO 
Decomposition 
of HA and TTCP 
(volatilization of 
P) 
- 
Calcium hydroxide 
and calcium 
carbonate 
Ca(OH)2 
Reaction of CaO 
with humidity 
and CO2 (on 
contact with air or 
body fluids) 
- 
Amorphous calcium 
phosphate (ACP) 
Variable 
Melting of HA 
and quenching 
- 
a-Tricalcium 
phosphate (a-TCP) 
a-Ca3(PO4)2 
(monoclinic) 
Thermal 
decomposition 
of HA 
25.5 
b-Tricalcium 
phosphate (b-TCP) 
b-Ca3(PO4)2 
(trigonal) 
Phase transition 
on cooling from 
a-TCP 
28.9 
Tetracalcium 
phosphate (TTCP) 
Ca4(PO4)2O 
Thermal 
decomposition 
of HA 
38 
Oxyhydroxyapatite 
(OHap) 
Ca10(PO4)6Ox(OH)2-2x 
De-hydration 
of HA 
- 
Hydroxyapatite 
(HA ) 
Ca10(PO4)6(OH)2 
(stoichiometric) 
- 116.8 
The formation of some of the phases found in coatings can 
be easily explained by the thermal stability of apatite. The 
amorphous calcium phosphate (ACP) phase, which is generally 
the most abundant foreign phase found in coatings, is 
considered to originate from the fast quenching of the liquid 
phase upon reaching the target, as schematized in Fig. 2. This 
amorphous phase is more abundant in coatings made with one 
pass of the plasma torch (Fig. 2). The TTCP and TCP phases 
are considered to correspond to phases formed during the 
heating of the HA particles, inside the grain, in areas where the 
temperature is in the narrow gap between the maximum 
stability temperatures of the apatite phase and the liquid phase. 
Another possibility is that these phases are formed during the 
cooling period if the rate of cooling of the liquid fraction is 
slow enough to allow the nucleation of these phases. In 
coatings formed by multiple torch passes, re-heating and a 
slower cooling rate could favor the re-formation of apatite from 
the decomposition products, as it is the most stable phase, 
having a large domain of thermal stability. 
OA is considered by most researchers to exist in solid 
solution with HA [16-18]. It likely exists in deeper zones of the 
in-flight particles where the temperature is lower (in the range 
1050-1350 °C). It seems reasonable to consider that the OA 
content varies within the flying particles (Fig. 2). Rehydration 
of the OA fraction during cooling in air, which can be 
considered as re-hydroxylation, has been shown to be active at 
temperatures as low as 400 °C [17]. 
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Figure 2. Sequence of events during deposition of a semi-molten HA 
particle impinging on a roughened substrate. 
The formation of CaO, which is often observed in coatings 
rich in amorphous phase obtained at high power, remains, 
however, unexplained by phase diagrams. Some researchers 
consider that the liquid phase may in fact contain CaO. This 
assumption is supported by experimental data on the fast 
quenching of totally melted HA particles, which shows only an 
amorphous phase and CaO [6]. In this case, however, one may 
wonder why CaO is not observed systematically in all coatings 
containing an amorphous phase but is only seen in some of 
them. Several hypotheses can be proposed: CaO forms only 
nanocrystals which are difficult to detect; CaO reacts with 
water and/or CO2 from the atmosphere once the coating has 
been formed, giving poorly crystalline or amorphous phases; 
the solubility of CaO in the melted phosphate varies with 
temperature. CaO is the most refractory phase in coatings with 
a melting point of 2613 °C. 
Most coatings obtained in argon plasma do not show any 
variation in their chemical composition and after plasma 
spraying their Ca/P ratio is the same as that of the initial apatite 
powder. However, very high powers and/or reductive plasmas, 
containing hydrogen, may induce a loss of phosphorus and are 
associated with an increase in the Ca/P ratio. 
The global chemical phase composition and crystallinity 
of the coatings are determined, in most countries, according to 
ISO standards, based on the analysis of XRD patterns. 
However, certain characteristics of the coatings which have to 
be considered for their biological behavior have not been 
standardized, such as OA content, amorphous phase content 
(not only crystallinity, which is a different parameter), and 
phase distribution. 
The most important parameter is certainly the amorphous 
phase content. Old standards (AFNOR S 94-068) distinguished 
between crystallinity and amorphous phase content. Although a 
large amount of amorphous phase affects the crystallinity of the 
coating, other parameters are also involved in the crystallinity, 
such as the re-formation of poorly crystalline apatite during 
cooling or re-heating in multiple torch passes and 
heterogeneous solid solution formation between OHAs and 
HAs, which increase the level of strain and contribute to the 
XRD background. The determination of the real amount of 
amorphous phase by XRD is rather tedious and imprecise; 
however, Raman spectroscopy allows a clear identification of 
the amorphous component, which is distinct from the 
crystalline apatite phase. The phase distribution is also crucial 
for the evolution of the coating after implantation. 
4. Phase distribution in coatings
Plasma-sprayed coatings have been shown to be very 
inhomogeneous. Several methods have been proposed for 
evaluating the distribution of phases in coatings, including 
optical microscopy [7], scanning electron microscopy (SEM), 
backscattered electron imaging, and scanning cathode- 
luminescence microscopy [8]. A few studies have used 
microdiffraction [9]. The amorphous phase appears as the major 
foreign phase in most commercial HA coatings. It has been 
identified in close proximity to the metal surface, whose high 
thermal conductivity facilitates quenching of the molten phase. 
TCP and TTCP phase formation resulting from the 
decomposition of OA between 1050 °C and 1550 °C should 
occupy the same areas; however, these phases are generally 
present in very small amounts in commercial HA coatings and 
their distribution is not well known [10]; in some coatings they 
do not appear at all. Several explanations can be given, such as 
the existence of supercooled liquid in the narrow window of 
stability of TCP and TTCP, which would favor the formation of 
OHA, whose nucleation would be facilitated by its abundance in 
the coating. The reformation of apatite from these phases, which 
should be in close proximity in multiple coatings, also seems 
likely [11]. The OA fraction is also an important characteristic 
 of the coatings, but as its XRD pattern is very close to that of 
apatite, it is very difficult to identify. 
Information about the morphological changes at the 
surface and interface of coatings can be obtained from SEM 
observations, but a detailed structural chemical analysis of the 
coatings in these regions is still lacking. Raman scattering 
allows local investigations of the coating’s heterogeneity. It is a 
unique tool providing information on the structure and short- 
range order of amorphous and crystalline phases [19-21]. 
Moreover, Raman imaging based on different strategies from a 
given dataset may provide a powerful means of studying 
structural changes and visualizing the distribution of phases 
within heterogeneous plasma-sprayed HA coatings. All mineral 
phases present in a coating can potentially be distinguished by 
Raman spectroscopy in the n1PO4 domain. An example of 
micro-Raman spectroscopic imaging collected across an HA 
coating cross-section is shown in Fig. 3 The ACP is 
characterized by a broad Raman line at 950 cm-1 and all 
crystalline phases show lines distinct from that of apatite at 
961 cm-1 (Fig. 4). OA, difficult to distinguish by other methods, 
shows very specific Raman scattering lines at about 951 cm-1 
and 966 cm-1, which have been assigned respectively to the 
vibration of phosphate ions close to a vacancy and close to an 
O2- ion [17]. CaO is the only phase which cannot be detected in 
this domain. 
(a) (b) (c) 
Figure 3. Representation of micro-Raman spectroscopic images of a 
HA coating cross section showing the phases distributions: 
ACP (a); HA (b) and OA (c). 
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HA (961 cm-1)
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Figure 4. Raman spectral characteristics of phosphate ions in various 
calcium phosphate salts between 940 and 970 cm-1. 
The most accurate mapping of the phases in HA coatings 
can be obtained by Raman imaging. Imaging of the phase 
distribution using Raman scattering involves curve fitting in the 
n1PO4 domain, extraction of the characteristic line(s) associated 
with specific phases, and mapping of their relative amounts 
[12]. It should be noted that without standardization, the data 
represent only the relative integrated intensities of lines 
associated with a specific phase and their relative variation, not 
their content in the coating. Figure. 3 shows the distributions of 
the amorphous component (Fig. 3(a)), HA (Fig. 3(b)), and OA 
(Fig. 3(c)) in a cross section of a HA coating obtained using a 
low-energy plasma spraying device [11]. The lamellar structure 
of the plasma-sprayed coating appears clearly on all these 
images; however, the limits of individual splats are difficult to 
distinguish. Heterogeneous structures much smaller than the 
particles are also observed, suggesting rupturing of grains and 
splitting on impact. The amorphous phase appears in close 
proximity to the metal surface but not directly on the surface, 
probably because the plastic deformation of the solidifying 
liquid phase on the impact results in a rejection of this phase to 
the periphery of the splat, whereas the solid core, containing 
mostly HA, reaches the surface. The domains rich in OA are 
relatively narrow and dispersed. Two types of OA-rich domain 
can be distinguished as those found within the amorphous 
phase, which may correspond in part to a recrystallization 
process, and those contiguous to HA domains, possibly formed 
by dehydration during particle flight. HA-rich domains can be 
found directly in contact with the metal. It is clear that HA-rich 
domains exist in zones with low amorphous content and 
inversely. 
In addition to a heterogeneous distribution of phases in 
terms of thickness in the deposit cross section, there is also a 
heterogeneous distribution on the surface itself and very 
different Raman spectra are collected depending on the location 
(Fig. 5) [12]. Therefore, Raman micro-spectroscopy can be 
used as a routine non-destructive tool to obtain rapid analysis 
of the composition of apatite coatings and grains. This 
technique could be adapted for the chemical characterization of 
coatings applied directly on biomedical implants. 
Figure 5. Raman spectra at various points on the surface of a HA 
coating showing its heterogeneity. 
 The heterogeneities of plasma-sprayed coatings affect 
their biological behavior. 
5. Physical-chemical properties of HA coatings and
their effect on biological behavior
Several physical-chemical properties of the coatings affect 
biological behavior, namely the solubility of mineral phases, 
hydration characteristics, and propensity to hydrolyze or 
transform spontaneously into more stable compounds. 
5.1. Solubility of mineral phases and biodegradation 
The biodegradation of calcium phosphates has often been 
related to their solubility, and this relationship has been 
confirmed by experimental data [22]. According to their 
solubility product, the phases found in plasma-sprayed HA 
coatings can be arranged in order of decreasing 
biodegradability (Table 1). Among these phases, one may 
however distinguish those which should spontaneously dissolve, 
because their solubility product is higher than the ion product 
of body fluids, and those for which the dissolution is mediated 
by cellular activity. The phases belonging to the former type, 
namely CaO, ACP, and a-TCP, cannot remain as long as they 
are in contact with body fluids. Due to the spraying process, 
however, some phases can be embedded in the accumulated 
splats, where they are not accessible to body fluids or cells, 
allowing them to remain unaltered until cracks or dissolution 
paths reach them. 
5.2. Hydration and hydrolysis reactions 
Several phases formed at high temperature are not stable 
in aqueous media and may transform more or less rapidly into 
other compounds. This is the case of CaO, which hydrolyzes 
into Ca(OH)2. This reaction leads to a 40% increase in volume 
and may lead to a rupture of the coating. In addition, in the 
presence of phosphate ions from body fluids, a precipitate may 
form with the calcium ions released from the very soluble 
Ca(OH)2. 
The amorphous phase can also hydrolyze into apatite. This 
reaction first involves a hydration of the amorphous phase [22]. 
It has been suggested that this hydration process could also lead 
to fracture of the coating [23]. Once hydration has occurred, 
ACP transforms rather rapidly into apatite [24]. Several 
investigations have shown that the ACP content decreases and 
the crystallinity increases after contact with body fluids or their 
model solutions (Ringer solution or simulated body fluid (SBF) 
solution) due to the hydrolysis of ACP into hydroxylated 
apatite. 
a-TCP and TTCP hydrolyzes have also been observed and, 
like ACP, they lead to the formation of hydroxylated apatite 
[25,26]. These reactions can be rapid at body temperature (a 
few tens of minutes when the phases are in a powder state) and 
they are involved in the setting of several hydraulic mineral 
cements for orthopedic applications. 
Although b-TCP has been shown to hydrolyze into apatite 
in aqueous media, the reaction at body temperature seems 
extremely slow and it is generally not mentioned; however, 
when considering months of implantation, it might be involved. 
The transformation of OA into HA by hydrolysis requires 
the diffusion of water molecules into the apatite structure. 
Surface hydrolysis may be responsible; however, the diffusion 
of water molecules inside the lattice at body temperature would 
be much too slow. Another possibility is a dissolution- 
reprecipitation process, as OA has been claimed to be more 
soluble than HA [18]. However, very often, no accurate phase 
analysis of coatings is conducted and thus this question remains 
open. These reactions and their effects on coatings are 
summarized in Fig. 6. 
Figure 6. Scheme of reactions at the coating aqueous medium interface. 
6. Biological role and biological consequences of HA 
coating composition
The main role of a coating is to improve bone integration 
and the stability of the interface between the implant and the 
tissue. This role is essential in the first months after 
implantation, as most failures of implants are related to poor 
stability in the biological tissue. However, as bone remodels 
continuously, it seems important for some biological activity to 
occur on the implant surface during its life span. Several 
studies have shown the positive effect of coatings on bone 
integration during the first months after implantation [28-30]. 
In the long term, however, the difference between coated and 
uncoated implants generally tends to diminish and coated 
implants have sometimes been reported to deteriorate [31]. 
The preferential dissolution of foreign mineral phases 
weakens coating integrity and cohesion. The events associated 
with mechanical stress may lead to delamination and scaling and 
 to the release of particles [31-33]. Potentially, such a release of 
small particulates may lead to inflammatory reactions, which do 
not seem to have been observed in most cases. Nevertheless, the 
actual tendency is to prefer coatings with a high crystallinity to 
avoid weakening by dissolution of the heterogeneously 
distributed amorphous phase. Another precaution is to ensure 
that either very large particles or small degradable particles, 
which would have little inflammatory power, are generated 
during degradation. 
However, the presence of hydrolyzable phases has also 
been seen as an advantage as it allows the formation of a neo- 
formed layer of carbonated apatite analogous to the mineral 
phase of bone. The development of such layers is considered an 
essential step in the colonization of the implant surface by 
osteoblast cells and bone reconstruction. Another cellular effect 
of the hydrolysis reaction, especially in the case of CaO and 
TTCP, is the local alkalinization of the surrounding media, 
which could inhibit osteoclast activity. 
Most studies have shown that a weakness of plasma- 
sprayed coatings is the attachment to the metal surface. 
Although chemical reactions with metal oxide layers cannot be 
excluded, their role in the adherence of the coating seems 
marginal and the main parameters to consider are the surface 
roughness and the thickness and composition of the coating, as 
discussed in previous studies [2,13]. This mechanical weakness 
plays a role in degradation, as underlayers rich in a soluble 
amorphous phase can be uncovered. A second problem with 
HA-coated dental implants is the possible promotion of bone 
infection. Recent developments have addressed some of these 
drawbacks. 
7. Recent developments
Three types of development can be distinguished: that 
aimed at improving the mechanical properties and adhesion to 
the substrate, that claiming a therapeutic activity, and that aimed 
at improving microstructure and crystallinity. 
7.1 Mechanical properties and adhesion 
Several approaches have been made to improve the 
mechanical resistance of coatings and their adhesion to the 
substrate. The most successful incorporate ZrO2 [34] or other 
ceramic oxides and use graded co-spraying of HA and titanium 
[35] or titanium oxide. In these coatings, the proportion of 
apatite co-deposited increases progressively from the metallic 
substrate to the surface. However, the implantation of coatings 
with ZrO2 has led to poor biological results with lower adhesion 
of bone to the coating [36]. Other coatings have apparently not 
been tested in vivo. There are still improvements to be made in 
this domain. 
7.2 Coatings with therapeutic activity 
The second field of development concerns the biological 
activity of coatings. Two approaches have been proposed: the 
association of coatings with growth factors or active molecules 
and the use of active mineral ions. The first one is rather limited 
as the surface area of plasma-sprayed HA coatings is low. The 
second one seems more promising and several biologically 
active elements or their combinations have been proposed: Ag+, 
Cu2+, and Zn2+ ions for their antibacterial properties, Sr2+ for its 
anti-osteoporotic activity, and silicon oxide to improve bone 
formation. 
7.3 Improvement of microstructure and crystallinity 
The third type of development is more specifically related 
to the physical-chemical properties of the coatings and their 
biological consequences. Increases in coating crystallinity may 
result from the choice of plasma-spraying conditions and several 
reports have been made. The use of mini- or even micro-torches 
working at low energy has been promoted [12]. These systems 
need smaller particulates but they produce coatings with high 
crystallinity and have several other advantages such as better 
homogeneity of composition within the particle and within the 
coating and thus a lower amount of metastable phases along 
with better control of coating microporosity. The use of phases 
other than HAs, especially fluorapatites, fluorhydroxyapatites, 
and more recently chlorapatites [12], has also been proposed. 
Unlike HA, fluor- and chlor-apatites melt without 
decomposition. Although some of these coatings have been 
tested with some success, they have not yet been commercially 
applied. The improvement of crystallinity can also be obtained 
by post-treatments: thermal and hydrothermal treatments and 
treatments in solutions have been applied [37]. There is however 
a risk of deterioration of the mechanical integrity of the coating. 
8. Conclusion
Plasma-sprayed coatings are largely used in many countries. 
Since the first experiments, considerable progress has been 
made, especially in the understanding of the characteristics of 
coatings and their biological behavior. Several means of 
improvement have been explored; however, the problems of 
coating adhesion and mechanical strength remain. Other coating 
processes have been investigated, especially low-temperature 
coating, which offers more flexibility concerning, in particular, 
the types of apatite used (e.g., non-stoichiometric, biomimetic, 
and carbonated apatites), but without dethroning, at present, 
plasma spraying. 
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